Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To investigate the expressions of CD33 and CD13 in newly diagnosed multiple myeloma (MM) patients and its relationship with prognosis.
Methods: It was retrospectively observed that the expression of CD33 and CD13 in 121 MM patients who were newly diagnosed from January 2014 to January 2020, and the relationship between the expressions of CD33 and CD13 and patients prognosis was analyzed.
Results: Among the 121 newly diagnosed MM patients, there were 30 patients (24.8%) in the CD33 group and 12 patients (9.9%) in the CD13 group. Kaplan-Meier analysis showed that, compared with the CD33 group, the progression-free survival (PFS) time and overall survival (OS) time were significantly shortened in MM patients in CD33 group (PFS 17.5 vs 23 months, P=0.000; OS 18.5 vs 25 months, P=0.000); and the PFS time and OS time of MM patients in the CD13 group were also significantly shortened than those in CD13 group (PFS 21 vs 22 months, P=0.012; OS 25 vs 26 months, P=0.006). Cox regression analysis showed that CD33 and CD13 were independent adverse prognostic factors in MM patients (CD33: P=0.000;CD13: P=0.003).
Conclusion: CD33 and CD13 are prognostic risk factors in patients with MM.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.19746/j.cnki.issn.1009-2137.2022.01.024 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case report: Experience of a rare case of primary acute mast cell leukemia.
Leuk Res Rep
April 2025
Department of Hematology, Peking University First Hospital Taiyuan Branch (Taiyuan Central Hospital of Shanxi Medical University), No. 256, Fendong Street, Xiaodian District, Taiyuan, Shanxi 030009, PR China.
Backgrounds: Mast cell leukemia (MCL) is a rare and aggressive form of systemic mastocytosis with a poor prognosis. Understanding the different therapeutic responses to corticosteroids in MCL is crucial for improving patient outcomes.
Case Presentation: We present a case of a 74-year-old Chinese female with primary acute MCL who exhibited different responses to dexamethasone and methylprednisolone.
[Clinical and Laboratory Characteristics of Acute Myeloid Leukemia, Myelodysplasia-Related].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
June 2025
Department of Clinical Laboratory Medicine, The 900th Hospital of Joint Logistics Support Force, PLA ,Fuzhou 350025, Fujian Province, China.
Objective: To understand clinical and laboratory characteristics of acute myeloid leukemia, myelodysplasia-related (AML-MR).
Methods: Blood sample of one patient with AML-MR admitted to our hospital in September 2021 was collected and synthetically analyzed by using techniques including complete blood cell count, peripheral blood and bone marrow cell morphology, bone marrow pathology and immunohistochemistry, hematology examination, flow cytometry (FCM), chromosome karyotype analysis and molecular pathology. The clinical and laboratory characteristics of AML-MR were analyzed and summarized according to the World Health Organization (WHO) standards.
Simultaneous Onset of Acute Myeloid Leukemia and Decompensated Cirrhosis: A Rare Case.
Cureus
June 2025
Gastroenterology, HCA Florida Blake Hospital, Bradenton, USA.
Acute myeloid leukemia (AML) is a hematologic malignancy marked by uncontrolled proliferation of abnormal myeloid precursor cells, while cirrhosis involves progressive hepatic fibrosis and architectural distortion. Despite differing pathophysiologies, both can present with overlapping clinical features, complicating the diagnostic process. We present the case of a 78-year-old female with a one-month history of bilateral lower extremity edema, dyspnea, fatigue, anorexia, low-grade fever, and progressive abdominal distension.
View Article and Find Full Text PDFMyeloid sarcoma presenting as intestinal obstruction: A case report of the first presentation of acute myeloid leukemia.
Int J Surg Case Rep
August 2025
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. Electronic address:
Introduction And Importance: Myeloid sarcoma (MS), a rare extramedullary tumor composed of immature myeloid cells, most commonly affects the skin, lymph nodes, and gastrointestinal tract. Rarely, it presents in isolation or in pediatric patients. Misdiagnosis is frequent due to its morphological similarity to lymphomas and lack of clinical context.
View Article and Find Full Text PDFVery Rare Coexistence of Inversion (16), Trisomy 8, and t(9;22) in a Chronic Myeloid Leukemia Patient Progressing to Myeloblastic Crisis.
J Assoc Genet Technol
January 2025
Institutional affiliation: Cytogenetics Laboratory, Cancer Biology Department, The Gujarat Cancer and Research Institute, Asarwa, Ahmedabad-380016, Gujarat, India.
Chronic myeloid leukemia (CML) is typically characterized by the presence of the BCR-ABL1 fusion gene on chomosome 22 resulting from a t(9;22)(q34;q11.2) translocation. We report a case of a 59-year-old female with CML in the chronic phase, initially presenting with thrombocytosis and diagnosed with t(9;22) via conventional karyotyping and fluorescence in situ hybridization (FISH).
View Article and Find Full Text PDF